Binghamton University, State University of New York will play a key role in a federal grant of up to $42.8 million to develop ...

New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

A major cause of inflammatory bowel disease (IBD) has been discovered by UK scientists. They found a weak spot in our DNA that is present in 95% of people with the disease. It makes it much easier for ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease (IBD) was associated with few ...

Takeda Canada Inc. ("Takeda") announces new data highlighting the impact Inflammatory Bowel Disease (IBD) has on Canadians. The data reveals insights into how the disease affects daily life, the ...

TD Cowen analyst Tara Bancroft has maintained their bullish stance on XNCR stock, giving a Buy rating yesterday. Tara Bancroft has given her ...

After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...

WEDNESDAY, Nov. 6, 2024 (HealthDay News) -- A simple nasal swab might help doctors predict the severity of a person’s COVID ...